| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/03/2008 | CN100415294C Medicine for treating and/or preventing hepatitis B |
| 09/03/2008 | CN100415243C Composition of water soluble Azithromycin salt |
| 09/03/2008 | CN100415238C Medicine composition for treating hepatitis |
| 09/03/2008 | CN100415237C Aciclovir compositions containing dimethicone |
| 09/03/2008 | CN100415234C Antifungal composition with enhanced bioavailability |
| 09/03/2008 | CN100415232C Medicine composition for treating viral hepatitis and its preparing method |
| 09/03/2008 | CN100415231C Osmotic pump type controlled release preparation of kurarinone and its preparing method |
| 09/03/2008 | CN100415230C Dispersion tablets of penicillin V potassium, and its preparing method |
| 09/03/2008 | CN100415229C Itraconazole soft capsule, and its preparation method |
| 09/03/2008 | CN100415228C Medicine containing galangin and preparation method thereof |
| 09/03/2008 | CN100415221C Curcumin lyophilized liposome for injection and its preparing method |
| 09/03/2008 | CN100415212C An oral preparation containing caderofloxacin lactate |
| 09/03/2008 | CN100415211C AIDS drug didanosine granula composition and its preparation method |
| 09/02/2008 | US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 09/02/2008 | US7420028 Replikins and methods of identifying replikin-containing sequences |
| 09/02/2008 | US7420003 Compounds and a novel process for their preparation |
| 09/02/2008 | US7419997 e.g. N-(6-bromo-2,3,4,9-tetrahydro-1H-carbazol-1-yl)-2-fluorobenzenesulfonamide; viricide; papillomaviruses, polyomaviruses, retroviruses, papovaviruses, adenoviruses |
| 09/02/2008 | US7419993 Triazolo-epothilones |
| 09/02/2008 | US7419987 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them |
| 09/02/2008 | US7419973 Phosphonocephem compound |
| 09/02/2008 | US7419967 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections |
| 09/02/2008 | US7419966 Viricides; human t-cell leukemia, lymphoma virus |
| 09/02/2008 | US7419824 BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof |
| 09/02/2008 | US7419816 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
| 09/02/2008 | US7419807 High molecular weight; isolated nucleic acid; use in detecting antibodies in test sample; diagnostic kit |
| 09/02/2008 | US7419804 CASH (Caspase Homologue) with death effector domain, modulators of the function of FAS |
| 09/02/2008 | US7419789 Method of inhibiting binding of Dengue virus to a human cell with DC-SIGN blockers |
| 09/02/2008 | US7419673 Anti-viral agents prepared from sea lettuce as raw material |
| 09/02/2008 | US7419672 Genes and proteins, and their use |
| 09/02/2008 | US7419671 For therapy and prophylaxis of Porphyromonas gingivalis infection |
| 09/02/2008 | CA2316052C Sustained release formulations of water soluble peptides |
| 09/02/2008 | CA2303478C Group a streptococcal vaccines |
| 09/02/2008 | CA2282666C Novel erythromycin derivatives, method of preparation and application as medicines |
| 09/02/2008 | CA2243237C Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application |
| 09/02/2008 | CA2175577C Receptor on the surface of activated t-cells: acts-4 |
| 09/02/2008 | CA2146973C Uses of tgf-.beta. receptor fragment as a therapeutic agent |
| 08/28/2008 | WO2008103949A1 Modulators of pharmacokinetic properties of therapeutics |
| 08/28/2008 | WO2008103899A1 Preparation and utility of non-nucleoside reverse transcriptase inhibitors |
| 08/28/2008 | WO2008103637A1 Compounds for the treatment of hepatitis c |
| 08/28/2008 | WO2008103636A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors |
| 08/28/2008 | WO2008102880A1 Antimycotic patch |
| 08/28/2008 | WO2008102036A1 Method for obtaining a freeze-dried, stable extract from plants of the allium genus |
| 08/28/2008 | WO2008101905A1 Aryl carboxylic acid cyclohexyl amide derivatives |
| 08/28/2008 | WO2008101665A1 Macrocyclic compounds as hcv ns3 protease inhibitors |
| 08/28/2008 | WO2008101514A1 Nucleoside analogues for the treatment of viral infections and methods for preparing them |
| 08/28/2008 | WO2008101349A1 Recombinant viral vectors for prevention and protection against alphavirus infection |
| 08/28/2008 | WO2008083239A3 Compositions and methods for stimulating an immune response |
| 08/28/2008 | WO2008073891A3 Salmonella vaccine in poultry |
| 08/28/2008 | WO2008033851A3 Use of 2-6- (3-amino-piperidin-l-yl) -3-methyl-2, 4-dioxo-3, 4-dihydr0-2h-pyrimidin-1-ylmet hyl-4-fluoro-benzonitrile |
| 08/28/2008 | WO2008019823A3 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
| 08/28/2008 | WO2007113223A3 Immunogenic composition |
| 08/28/2008 | US20080207774 Incorporating antimicrobial ingredients into latex during emulsion polymerization instead of after; allows use of higher concentrations of a wide range of bioactive ingredients, including highly hydrophobic ones; homogenous distribution; personal care, textiles, plastics; deodorants, disinfectants |
| 08/28/2008 | US20080207770 Compositions enriched in phenolic compounds and methods for producing the same |
| 08/28/2008 | US20080207760 Pharmaceutical Compositions For and Methods of Inhibiting Hcv |
| 08/28/2008 | US20080207746 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis; using halogenated xanthene compound |
| 08/28/2008 | US20080207688 Novel Piperidine Derivatives |
| 08/28/2008 | US20080207687 Quinoline Derivatives as Antibacterial Agents |
| 08/28/2008 | US20080207686 Antibiotics |
| 08/28/2008 | US20080207680 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents |
| 08/28/2008 | US20080207642 Respiratory system disorders; asthma; chronic obstructive pulmonary diseases; autoimmune diseases; antiproliferative agents; anticancer agents |
| 08/28/2008 | US20080207634 Chemical Compounds |
| 08/28/2008 | US20080207620 Modulators of pharmacokinetic properties of therapeutics |
| 08/28/2008 | US20080207619 Diaminopyrimidines as P2X3 and P2X2/3 modulators |
| 08/28/2008 | US20080207618 6- (Heterocyclyl-substituted Benzyl) -4-Oxoquinoline Compound and Use Thereof as HIV Integrase Inhibitor |
| 08/28/2008 | US20080207603 Methods of Chemical Synthesis and Purification of Diaminophenothiazinium Compounds Including Methylthioninium Chloride (Mtc) |
| 08/28/2008 | US20080207597 Homopiperazine compounds that inhibit ribosomal frameshifting by binding to rna pseudoknot structure of sars coronavirus |
| 08/28/2008 | US20080207586 6-[1-Hydroxyethyl]-4-methyl-7-oxo-3[[-5-(sulfamoylaminomethyl)pyrrolidin-3-yl]thio]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid or S-4661; storage stability, antibiotics |
| 08/28/2008 | US20080207583 Process For Preparing Granulates Comprising Amoxicillin |
| 08/28/2008 | US20080207567 Administering sphingosine-1-phosphate (S1P)modulator or agonist such as a (benzo)thiophene derivative; immunosuppression; hepatitis C virus infections |
| 08/28/2008 | US20080207554 Oligonucleotides with phosphotriester linkages; ribonuclease L activators; antineoplastic agents, namely against leukemias, viricides, parasiticides for Chagas' Disease; nucleotide chemical synthesis |
| 08/28/2008 | US20080207550 Immunomodulatory polynucleotides and methods of using the same |
| 08/28/2008 | US20080207537 Reducing agent and oxidizing agent are separately disposed and sequentially administered to a nail; oxidizer increases permeability; thioglycolic acid derivative and hydrogen peroxide; psoriasis; fungicides |
| 08/28/2008 | US20080207536 Erythromycin-11,12-carbamate derivatives; Grampositive, Gramnegative or anaerobic bacteria; Staphylococcus, Streptococcus, Enterococcus, Hemophilus, Moraxella, Chlamydia, Mycoplasma, Legionella, Mycobacterium, Helicobacter, Clostridium, Bacteroides, Corynebacterium, Baccillus or Enterobactericeae |
| 08/28/2008 | US20080207535 Polytetrafluoroethylene (PTFE), polyoxyethylene glycol (PEG), maleic anhydride (MA), and penicillin (ampicillin or gentamicin) are reacted to yield penicillin-PEG-MA-PTFE, which inhibits Grampositive bacteria |
| 08/28/2008 | US20080207532 Use of Nordihydroguaiaretic Acid Derivatives in the Treatment of Drug Resistant Cancer, Viral and Microbial Infection |
| 08/28/2008 | US20080207528 Administering derivatives of 4-(3-pyrrolidinyloxy)quinoline |
| 08/28/2008 | US20080207491 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections |
| 08/28/2008 | US20080206835 Methods and Compositions Relating to Gene Silencing |
| 08/28/2008 | US20080206380 Preventing Agent Against Drug-Resistant Bacterial Infection |
| 08/28/2008 | US20080206364 Bathing the skin in nitric oxide in a sealed environment, stripping NO from the evacuated gas followed by nitrogen dioxide; alopecia areata, psoriasis, vitiligo, epidermolysis bullosa, scleroderma, antiphospholipid syndrome, Sjorgren's Syndrome and Raynaud's Syndrome |
| 08/28/2008 | US20080206329 Tablet; water-insoluble release-retarding ethyl cellulose, ammonioalkyl methacrylate copolymer; simple, conventional pharmaceutical processing; no complex retention mechanisms; stable, bioequivalent to commercially available CIPRO XR; maintains therapeutic blood levels; enables once-a-day administration |
| 08/28/2008 | US20080206293 Absorbent substrate with a non-leaching antimicrobial activity and a controlled-release bioactive agent. |
| 08/28/2008 | US20080206283 Vaccine Against Sars |
| 08/28/2008 | US20080206276 Targeting Poly-Gamma-Glutamic Acid to Treat Staphylococcus Epidermidis and Related Infections |
| 08/28/2008 | US20080206269 stimulate the resuscitation of bacteria after true dormancy; cognate receptors, convertases, respective genes and inhibitors or mimetics |
| 08/28/2008 | US20080206268 HA-1 epitopes and uses thereof |
| 08/28/2008 | US20080206267 Inactivation Of Genes Of The Mep Pathway |
| 08/28/2008 | US20080206266 Carbohydrate ligand that specifically binds to a leczyme; nucleic acid sequence encoding a nonclassical MHC class I heavy chain; ability to associate with a beta 2 microglobulin; major histocompatibility complex transplantation molecules |
| 08/28/2008 | US20080206264 when bound by a highly potent human neutralizing monoclonal antibody specific for a V3 conformational epitope; immunogens for inducing broadly-neutralizing antibodies against HIV-1 as well as antagonists for inhibiting the binding of HIV-1 to the relevant co-receptors |
| 08/28/2008 | US20080206260 Chimeric Tbp-toxin proteins as mucosal adjuvants for vaccination against neisseriae |
| 08/28/2008 | US20080206259 Unique and specific combinations of polyclonal anti-TNF and anti-IL-6 antibodies directed to cytokines; high-risk patients, including immunocompromised patients such as surgical and other hospitalized patients, low birth weight infants, and burn and trauma victims |
| 08/28/2008 | US20080206214 Inhibition of pathogens by probiotic bacteria |
| 08/28/2008 | US20080206209 Myelinating or remyelinating dysmyelinated or demyelinated axons comprising: administering oligondendrocyte progenitor cells to dysmyelinated or demyelinated axons via intraventricular, intracallosal or intraparenchymal administration to brain, brain stem or spinal cord |
| 08/28/2008 | US20080206192 Treating cell proliferative disorders via administration of mixture comprising interleukin-21 and anti-cancer monoclonal antibody (Alemtuzumab) |
| 08/28/2008 | US20080206191 Compounds for the Treatment of Hepatitis C |
| 08/28/2008 | US20080206188 polyethylene glycol monomethyl ether or dimethyl ether, polyoxypropylene glycol; for an inflamed epithelium at risk of developing gut-derived sepsis from an intestinal pathogen; labeled package |
| 08/28/2008 | US20080206183 grafted with haptens or antigens, or an antibacterial or antifungal; hydrophobic polypeptides in the form of precipitates by polymerization of activated a-amino acid monomers in an aqueous solvent; polypeptide being capable of being resolubilized in said solvent; a-amino acid N-carboxyanhydride monomers |
| 08/28/2008 | US20080206159 Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions |
| 08/28/2008 | US20080206154 Kill, inhibit growth or prevent the production of endogenously expressed toxin; treatment of sepsis |
| 08/28/2008 | DE102007008419A1 4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate 4- (pyrrolopyridinyl) -pyrimidinyl-2-amine derivatives |